Videndannelse om lægemiddelbivirkninger i den pædiatriske population

Ugeskrift for Laeger

Volumn 175, Issue 6, 2013, Pages 342-345

  Aagaard, Lise ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD MORTALITY; DENMARK; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; EDUCATION; FACTUAL DATABASE; FEMALE; HUMAN; INFANT; MALE; MORTALITY; OFF LABEL DRUG USE; PEDIATRICS; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; DATABASES, FACTUAL; DENMARK; DRUG TOXICITY; FEMALE; HUMANS; INFANT; MALE; OFF-LABEL USE; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE;

EID: 84874573278     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006;5:703-18.
2. Mukattash T, Millership J, Collier P et al. Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol 2008;66:838-45.
3. Impicciatore P, Choonara I, Clarkson A et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001;52:77-83.
4. Aagaard L, Hansen EH. The occurrence of adverse drug reactions reported for psychostimulants in the paediatric population: a qualitative review of empirical studies. Neuropsychiatr Dis Treat 2011;7:729-44.
5. Aagaard L, Thirstrup S, Hansen EH. Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children. Pharmacoepidemiol Drug Saf 2009;18:401-11.
6. FDA Modernization Act of 1997. www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/MedicalDeviceProvisionsofFDAModernizationAct/ucm136671.htm ( 3. apr 2012).
7. Regulation EC No. 1901/2006 of the European Parliament and the Council of 12 December 2006 on Medicinal Products forPaediatric Use and Amending Regulation. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf ( 3. apr 2012).
8. Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol 2009;9:4.
9. www.produktresume.dk (3. apr 2012).
10. EudraLex. Volume 9 Pharmacovigilance: medicinal products for human use and veterinary products. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev9.htm (3. apr 2012).
11. WHO Collaboration Centre for Drug Statistics Methodology. 2012. www.whocc.no/atc_ddd_index/ (3. apr 2012).
12. Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 2010;70:481-91.
13. Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 2010;33:327-39.
14. Aagaard L, Hansen EH. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions. Br J Clin Pharmacol 2011;71:751-7.
15. Aagaard L, Hansen EH. Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade. BMC Research Notes 2010;3:176.
16. Aagaard L, Hansen EH. Adverse drug reactions reported for systemic antibacterials in Danish children over a decade. Br J Clin Pharmacol 2010;70:765-8.
17. Aagaard L, Hansen EW, Hansen EH. Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade. Eur J Clin Pharmacol 2011;67:283-8.
18. Aagaard L, Hansen EH. Cutaneous adverse drug reactions reported in children: a national register-based study. Br J Dermatol 2012 4. jul doi: 10.1111/j.1365-2133.2012.11133.x (epub ahead of print).
19. Star K, Norén GN, Nordin K et al. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf 2011;34:415-28.